30results about How to "Minimizes degradation" patented technology

This invention provides a system, method and apparatus for managing congestion on heterogeneous network communication links, the first communication link and second communication link being heterogeneous with respect to each other. The system, method and apparatus including a routing decision module, the routing decision module evaluating a queue of information packets scheduled for transmission across the first communication link to determine whether to generate a command signal to route a portion of information packets over the second communication link. The system, method and apparatus may further include a communication link threshold module, the communication link threshold module storing threshold limit values corresponding to a first communication link technology of the first communication link.

Methods and compositions for inhibiting articular cartilage degradation. The compositions preferably include multiple chondroprotective agents, including at least one agent that promotes cartilage anabolic activity and at least one agent that inhibits cartilage catabolism. The compositions may also include one or more pain and inflammation inhibitory agents. The compositions may be administered systemically, such as to treat patients at risk of cartilage degradation at multiple joints, and suitably may be formulated in a carrier or delivery vehicle that is targeted to the joints. Alternatively the compositions may be injected or infused directly into the joint.

A method and solution for perioperatively inhibiting a variety of pain and inflammation processes at wounds from general surgical procedures including oral / dental procedures. The solution preferably includes multiple pain and inflammation inhibitory at dilute concentration in a physiologic carrier, such as saline or lactated Ringer's solution. The solution is applied by continuous irrigation of a wound during a surgical procedure for preemptive inhibition of pain and while avoiding undesirable side effects associated with oral, intramuscular, subcutaneous or intravenous application of larger doses of the agents. One preferred solution to inhibit pain and inflammation includes a serotonin2 antagonist, a serotonin3 antagonist, a histamine antagonist, a serotonin agonist, a cyclooxygenase inhibitor, a neurokinin1 antagonist, a neurokinin2 antagonist, a purinoceptor antagonist, an ATP-sensitive potassium channel opener, a calcium channel antagonist, a bradykinin1 antagonist, a bradykinin2 antagonist and a mu-opioid agonist.

Disclosed is an organic light emitting display device including an anode, a cathode, a plurality of organic layers and a partition member. The plurality of organic layers is disposed between the anode and the cathode, where at least one layer is separated to minimize current leakage into neighboring pixels. The partition member is disposed between the neighboring pixels and configured to separate the plurality of organic layers. The least one separated layer includes a charge generation layer. Because at least one layer is separated, current leakage into neighboring pixels can be minimized. Accordingly, defects resulting from light leakage and the mixing of colors of light from neighboring pixels may be reduced and display quality is enhanced.

A method and solution for perioperatively inhibiting a variety of pain and inflammation processes at wounds from general surgical procedures including oral / dental procedures. The solution preferably includes at least one tumor necrosis factor (TNF) soluble receptor at dilute concentration in a physiologic carrier, such as saline or lactated Ringer's solution. The solution is applied locally and perioperatively to a surgical site during a surgical procedure for preemptive inhibition of pain and while avoiding undesirable side effects associated with oral, intramuscular, subcutaneous or intravenous application of larger doses of the agents.

A process to remove metal contaminants from a hydrocarbon solution of polyethylene is disclosed. The process comprises adding a primary alcohol and a β-diketone to a solution of polyethylene at a temperature within the range of 120° C. to 300° C. and contacting the solution with basic alumina. The process removes metal contaminants and minimizes degradation and condensation products, which can have a detrimental effect on polyethylene properties. The process provides polyethylene with low metal residues and good properties.

A method and solution for perioperatively inhibiting a variety of pain and inflammation processes at wounds from general surgical procedures including oral / dental procedures. The solution preferably includes at least one pharmacological agent that is a soluble receptor tyrosine kinase, and optionally additional multiple pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated Ringer's solution. The solution is applied by continuous irrigation of a wound during a surgical procedure for preemptive inhibition of pain and while avoiding undesirable side effects associated with oral, intramuscular, subcutaneous or intravenous application of larger doses of the agents.

This invention provides a system, method and apparatus for managing congestion on heterogeneous network communication links, the first communication link and second communication link being heterogeneous with respect to each other. The system, method and apparatus including a routing decision module, the routing decision module evaluating a queue of information packets scheduled for transmission across the first communication link to determine whether to generate a command signal to route a portion of information packets over the second communication link. The system, method and apparatus may further include a communication link threshold module, the communication link threshold module storing threshold limit values corresponding to a first communication link technology of the first communication link.

A video transmission system includes an encoder and a decoder. As video data is encoded, the system uses temporal or spatial prediction to reduce the number of bits needed to encode frames. An increase in the complexity of the data results when a scene change occurs. The scene change is detected for intra-frame and inter-frame frames by monitoring statistics for the macroblocks within the current frame. Once the scene change is detected, the encoder or the system takes actions to prevent latency, bit rate fluctuation or quality degradation for the video transmission.

An asphalt binder is provided, comprising 85 to 97.5 parts by weight of a bitumen and 16 to 2.5 parts by weigh of a polymer composition, wherein the polymer composition comprises:(i) from 2 to 8, preferably from 3 to 6 parts by weight of a styrenic block copolymer having at least two blocks of monovinylaromatic hydrocarbon (A) and at least one block of a conjugated diene (B), wherein the block copolymer composition has a vinyl content of at least 25% by weight, preferably from 25 to 40% by weight, based on the total diene content;(ii) from 0 to 5, preferably from 1 to 3 parts by weight of a styrenic diblock copolymer having one block of monovinylaromatic hydrocarbon (A) and one block of a conjugated diene (B); and(iii) from 0.5 to 3, preferably from 1 to 2.5 parts by weight of an ethylene-vinyl acetate copolymer,wherein the weight ratio of (i)+(ii):(iii) is from 2:1 to 6:1, preferably from 3:1 to 4:1. In addition, an asphalt mix is provided comprising 2 to 8 parts by weight of the asphalt binder of the present invention and 98 to 92 parts by weight of gap-graded aggregate or open-graded aggregate material.Furthermore, a porous pavement is claimed, produced from the open or gap-graded mixes, by compacting the asphalt mix mentioned above.

A fuel cell system that enables an assisted anode purge upon start-up is provided. The fuel cell system includes a fuel cell stack having a plurality of fuel cells with anodes and cathodes. The fuel cell stack has an anode supply manifold and an anode exhaust manifold in fluid communication with the anodes. The fuel cell system further includes a suction device in fluid communication with at least one of the anode supply manifold and the anode exhaust manifold. The suction device adapted to selectively draw a partial vacuum on the fuel cell stack during a start-up of the fuel cell system. Methods for starting the fuel cell system are also provided.

Disclosed is an organic light emitting display device including an anode, a cathode, a plurality of organic layers and a partition member. The plurality of organic layers is disposed between the anode and the cathode, where at least one layer is separated to minimize current leakage into neighboring pixels. The partition member is disposed between the neighboring pixels and configured to separate the plurality of organic layers. The least one separated layer includes a charge generation layer. Because at least one layer is separated, current leakage into neighboring pixels can be minimized. Accordingly, defects resulting from light leakage and the mixing of colors of light from neighboring pixels may be reduced and display quality is enhanced.

A method and solution for perioperatively inhibiting a variety of pain, inflammation, spasm and restenosis processes resulting from cardiovascular or general surgical, therapeutic and diagnostic procedures. The solution preferably includes multiple pain and inflammation inhibitory agents, including at least one local anesthetic agent, and spasm inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated Ringer's solution. Specific preferred embodiments of the solution of the present invention for use in cardiovascular and general vascular procedures also include anti-restenosis agents.

A method and composition for inhibiting a variety of pain, inflammation, spasm and restenosis processes resulting from cardiovascular or general vascular therapeutic and diagnostic procedures. The composition preferably includes multiple pain and inflammation inhibitory agents and spasm inhibitory agents. Specific preferred embodiments of the solution of the present invention for use in cardiovascular and general vascular procedures also may include anti-restenosis agents.

A method and solution for perioperatively inhibiting a variety of pain and inflammation processes at wounds from general surgical procedures including oral / dental procedures. The solution preferably includes at least one pharmacological agent that is an interleukin-1 (IL-1) soluble receptor, and optionally additional multiple pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated Ringer's solution. The solution is applied by continuous irrigation of a wound during a surgical procedure for preemptive inhibition of pain and while avoiding undesirable side effects associated with oral, intramuscular, subcutaneous or intravenous application of larger doses of the agents.

Method for extraction of biomass with water in order to separate hemicelluloses from a fibrous structure. The biomass is impregnated under reduced pressure with the extraction fluid in order to prevent the degradation of the components to be extracted. During extraction the extract is circulated through the fiber matrix in order to remove unwanted components from the extract. The extract is reused for extracting untreated biomass in order to increase the consistency of the extract.

A method and composition for inhibiting a variety of pain, inflammation, spasm and restenosis processes resulting from cardiovascular or general vascular therapeutic and diagnostic procedures. The composition preferably includes multiple pain and inflammation inhibitory agents and spasm inhibitory agents. Specific preferred embodiments of the solution of the present invention for use in cardiovascular and general vascular procedures also may include anti-restenosis agents.